Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified family nurse practitioner (FNP) joins a primary care
practice and receives federal authorization to prescribe controlled
substances. Before prescribing Schedule II medications independently,
which action is the highest priority to promote safe and legally
compliant prescribing?
A. Prescribe only a 7-day supply for all Schedule II medications.
B. Verify state prescribing requirements, register for required
prescription monitoring resources, and follow federal and state
regulations.
C. Require all patients receiving controlled substances to sign a pain
contract regardless of diagnosis.
D. Delegate review of controlled substance histories to office staff
before signing prescriptions.
Correct Answer: B
Rationale:
Advanced practice registered nurses (APRNs) must comply with both
federal and state laws governing controlled substance prescribing. This
includes obtaining appropriate licensure and DEA registration when
applicable, using the state's Prescription Drug Monitoring Program
(PDMP) if required, and adhering to state scope-of-practice regulations.
A universal 7-day limit is not required in all jurisdictions (A). Pain
agreements may be appropriate for selected patients but are not
universally required (C). The prescriber remains responsible for
independently reviewing relevant prescribing information before
issuing controlled substances (D).
,Question 2
An adult patient presents with symptoms of an uncomplicated urinary
tract infection. Before selecting an antibiotic, the APRN reviews the
patient's allergy history, renal function, current medications, local
antimicrobial resistance patterns, and pregnancy status. This approach
best demonstrates which prescribing principle?
A. Selecting the least expensive medication first
B. Individualizing pharmacotherapy using patient-specific clinical factors
C. Prescribing the broadest-spectrum antibiotic available
D. Avoiding laboratory data to prevent treatment delays
Correct Answer: B
Rationale:
Evidence-based prescribing requires integrating patient-specific
variables—including comorbidities, allergies, organ function,
medication interactions, pregnancy status, and local resistance data—
to optimize efficacy and minimize harm. Cost is one consideration but
should not supersede clinical appropriateness (A). Broad-spectrum
therapy should be reserved for appropriate indications to support
antimicrobial stewardship (C). Relevant laboratory and clinical data
improve prescribing decisions rather than delaying appropriate care
(D).
Question 3
, An APRN is prescribing a newly initiated antihypertensive medication.
Which action is most effective for improving medication adherence and
reducing preventable adverse outcomes?
A. Instruct the patient to read the pharmacy handout after leaving the
clinic.
B. Provide verbal counseling only because written instructions are often
ignored.
C. Explain the medication's purpose, expected benefits, common
adverse effects, monitoring plan, and use the teach-back method to
confirm understanding.
D. Delay counseling until the follow-up visit after determining whether
the medication is effective.
Correct Answer: C
Rationale:
Effective patient education is a core prescribing responsibility.
Counseling should include the indication, expected therapeutic effect,
dosing instructions, common adverse effects, monitoring requirements,
and when to seek medical attention. Using the teach-back method
helps confirm patient understanding and supports adherence. Verbal or
written information alone is less effective than combining education
with confirmation of comprehension. Delaying counseling until a
follow-up visit increases the risk of medication errors and
nonadherence.
Question 4
An older adult with chronic kidney disease takes eight prescription
medications from multiple specialists. Before prescribing an additional